» Articles » PMID: 11276203

A Point Mutation in CD28 Distinguishes Proliferative Signals from Survival Signals

Overview
Journal Nat Immunol
Date 2001 Mar 29
PMID 11276203
Citations 69
Authors
Affiliations
Soon will be listed here.
Abstract

Upon interaction with its ligand, B7, CD28 becomes phosphorylated on tyrosines. One tyrosine in particular (Y170 in mouse CD28, Y173 in human CD28) has received much attention. This is because it permits CD28 to recruit SH2-containing signaling molecules, including phosphoinositide 3 kinase, Grb2 and Gads. Using mice we employed a transgenic approach to express a tyrosine-->phenylalanine mutant form of CD28 that uncouples these SH2-mediated interactions from CD28. The CD28 mutant is unable to up-regulate expression of the prosurvival protein Bcl-xL, rendering the T cells more susceptible to radiation-induced death. Nonetheless, this mutated form of CD28 still prevents the induction of anergy and promotes T cell proliferation, interleukin 2 secretion and B cell help. Thus, we describe a single point mutation within the CD28 cytoplasmic domain that uncouples signals required for proliferation and survival.

Citing Articles

Pan-cancer mapping of single CD8 T cell profiles reveals a TCF1:CXCR6 axis regulating CD28 co-stimulation and anti-tumor immunity.

Tooley K, Jerby L, Escobar G, Krovi S, Mangani D, Dandekar G Cell Rep Med. 2024; 5(7):101640.

PMID: 38959885 PMC: 11293343. DOI: 10.1016/j.xcrm.2024.101640.


Potential Immunotherapy Targets for Liver-Directed Therapies, and the Current Scope of Immunotherapeutics for Liver-Related Malignancies.

Charles J, Vrionis A, Mansur A, Mathias T, Shaikh J, Ciner A Cancers (Basel). 2023; 15(9).

PMID: 37174089 PMC: 10177356. DOI: 10.3390/cancers15092624.


cis-B7:CD28 interactions at invaginated synaptic membranes provide CD28 co-stimulation and promote CD8 T cell function and anti-tumor immunity.

Zhao Y, Caron C, Chan Y, Lee C, Xu X, Zhang J Immunity. 2023; 56(6):1187-1203.e12.

PMID: 37160118 PMC: 10330546. DOI: 10.1016/j.immuni.2023.04.005.


Mapping the SLP76 interactome in T cells lacking each of the GRB2-family adaptors reveals molecular plasticity of the TCR signaling pathway.

Ruminski K, Celis-Gutierrez J, Jarmuzynski N, Maturin E, Audebert S, Malissen M Front Immunol. 2023; 14:1139123.

PMID: 37006259 PMC: 10057548. DOI: 10.3389/fimmu.2023.1139123.


Co-Stimulatory Receptor Signaling in CAR-T Cells.

Honikel M, Olejniczak S Biomolecules. 2022; 12(9).

PMID: 36139142 PMC: 9496564. DOI: 10.3390/biom12091303.